These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 34367250)
1. Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma. Zheng Z; Zhang Q; Wu W; Xue Y; Liu S; Chen Q; Lin D Front Genet; 2021; 12():690509. PubMed ID: 34367250 [TBL] [Abstract][Full Text] [Related]
2. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment. Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X Front Immunol; 2022; 13():903758. PubMed ID: 36016939 [TBL] [Abstract][Full Text] [Related]
3. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia. Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730 [TBL] [Abstract][Full Text] [Related]
4. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
5. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; AbrĂ£o FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma. Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY Front Oncol; 2021; 11():675545. PubMed ID: 34249715 [TBL] [Abstract][Full Text] [Related]
7. Identification and verification of a prognostic ferroptosis-related lncRNAs signature for patients with lung adenocarcinoma. Qi K; Liu XL; Chen XL; Song C; Peng JH; Xu JJ Am J Transl Res; 2022; 14(6):3698-3715. PubMed ID: 35836852 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma. Tian Q; Zhou Y; Zhu L; Gao H; Yang J Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361 [No Abstract] [Full Text] [Related]
9. Establishment and Validation of a Ferroptosis-Related Long Non-Coding RNA Signature for Predicting the Prognosis of Stomach Adenocarcinoma. Zhang S; Zheng N; Chen X; Du K; Yang J; Shen L Front Genet; 2022; 13():818306. PubMed ID: 35242169 [No Abstract] [Full Text] [Related]
10. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma. Yang L; Fan X; Zhou C; Wang Z; Cui Z; Wu X; Xu Z; Yang J; Zhang X Transl Lung Cancer Res; 2023 Aug; 12(8):1766-1781. PubMed ID: 37691861 [TBL] [Abstract][Full Text] [Related]
12. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma. Ma C; Li F; Gu Z; Yang Y; Qi Y Front Pharmacol; 2023; 14():1146840. PubMed ID: 37670938 [No Abstract] [Full Text] [Related]
13. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer. Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs. Peng L; Ji J; Zhang C; Wu Z; Sun Y; Fan K; Du W; Liu A; Jiao W J Thorac Dis; 2022 Oct; 14(10):3955-3974. PubMed ID: 36389299 [TBL] [Abstract][Full Text] [Related]
15. Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma. Fei X; Hu C; Wang X; Lu C; Chen H; Sun B; Li C Front Cell Dev Biol; 2021; 9():751490. PubMed ID: 34820377 [TBL] [Abstract][Full Text] [Related]
16. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma. Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889 [TBL] [Abstract][Full Text] [Related]
17. Identification of immune-associated lncRNAs as a prognostic marker for lung adenocarcinoma. He C; Yin H; Zheng J; Tang J; Fu Y; Zhao X Transl Cancer Res; 2021 Feb; 10(2):998-1012. PubMed ID: 35116427 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Robust Ferroptosis-Related Prognostic Signature in Lung Adenocarcinoma. Zhang A; Yang J; Ma C; Li F; Luo H Front Cell Dev Biol; 2021; 9():616271. PubMed ID: 34249899 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response. Gao M; Wang M; Chen Y; Wu J; Zhou S; He W; Shu Y; Wang X J Cancer Res Clin Oncol; 2024 Apr; 150(4):171. PubMed ID: 38558328 [TBL] [Abstract][Full Text] [Related]
20. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients. Peng J; Hao Y; Rao B; Zhang Z Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]